The new sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists are potential game changers for people with type 2 diabetes
Dulaglutide inhibits high glucose-induced endothelial dysfunction and NLRP3 inflammasome activation
Pulmonary aspiration during anesthesia or deep sedation
Holtkamp N, Malzer E, Zietsch J, Okuducu AF, Mucha J, Mawrin C, et al
THE CONTENT AVAILABLE THROUGH THIS SITE IS FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY AND IS NOT A SUBSTITUTE FOR THE PROFESSIONAL JUDGMENT OF A HEALTH CARE PROFESSIONAL IN DIAGNOSING AND TREATING PATIENTS
Mitochondrial proteomic analysis at 6 hours confirmed concurrent upregulation of fatty acid -oxidation, apoptosis prevention, antioxidant, and respiratory chain proteins (PMID 41901314